Israel: Fourth Subject Enrolled

On May 13, 2014, the fourth subject was enrolled in our ongoing Israeli study of MDMA-assisted psychotherapy for 10 subjects with chronic, treatment-resistant PTSD. The  subject prematurely reported last month as the fourth enrollment was not formally enrolled after the investigators determined the subject would not be appropriate for the study. This study is being conducted at the Beer Yaakov Mental Hospital in Israel and led by Principal Investigator Moshe Kotler, M.D.